OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
61
Results
Show all
Save search
Copy query
Show results for
Unknown
(61)
Release Date
2022
(12)
2021
(12)
2023
(10)
2025
(8)
2024
(8)
2019
(6)
2020
(4)
2015
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
A Cell-Surface GH9 Endo-Glucanase Coordinates with Surface Glycan-Binding Proteins to Mediate Xyloglucan Uptake in the Gut Symbiont Bacteroides ovatus.
Not available
S-EPMC6478033
|
biostudies-literature
Cite
Changes in the Prevalence of Child and Youth Mental Disorders and Perceived Need for Professional Help between 1983 and 2014: Evidence from the Ontario Child Health Study.
Not available
S-EPMC6463358
|
biostudies-literature
Cite
Six-Month Prevalence of Mental Disorders and Service Contacts among Children and Youth in Ontario: Evidence from the 2014 Ontario Child Health Study.
Not available
S-EPMC6463361
|
biostudies-literature
Cite
The 2014 Ontario Child Health Study-Methodology.
Not available
S-EPMC6463362
|
biostudies-literature
Cite
Prevalence and Correlates of Youth Suicidal Ideation and Attempts: Evidence from the 2014 Ontario Child Health Study.
Not available
S-EPMC6463356
|
biostudies-literature
Cite
Tracking Children's Mental Health in the 21st Century: Lessons from the 2014 OCHS.
Not available
S-EPMC6463360
|
biostudies-literature
Cite
Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
Not available
S-EPMC7657351
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
Not available
S-EPMC10626161
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets